Zürcher Nachrichten - 'Severe' pain: a New Yorker's experience of monkeypox

EUR -
AED 3.82096
AFN 72.95795
ALL 98.661714
AMD 411.511459
ANG 1.877014
AOA 948.73034
ARS 1067.056125
AUD 1.666545
AWG 1.872494
AZN 1.771352
BAM 1.958698
BBD 2.102991
BDT 124.462962
BGN 1.955092
BHD 0.392322
BIF 3079.326649
BMD 1.040274
BND 1.413464
BOB 7.212221
BRL 6.445753
BSD 1.041506
BTN 88.703395
BWP 14.405692
BYN 3.408043
BYR 20389.374639
BZD 2.094679
CAD 1.495654
CDF 2985.587061
CHF 0.934801
CLF 0.037342
CLP 1030.37048
CNY 7.591877
CNH 7.603151
COP 4589.689842
CRC 528.882548
CUC 1.040274
CUP 27.567267
CVE 110.42733
CZK 25.140322
DJF 184.877592
DKK 7.460384
DOP 63.191373
DZD 140.258299
EGP 53.137492
ERN 15.604113
ETB 132.577882
FJD 2.412552
FKP 0.823878
GBP 0.830144
GEL 2.923419
GGP 0.823878
GHS 15.309696
GIP 0.823878
GMD 74.899648
GNF 8998.227508
GTQ 8.024797
GYD 217.888779
HKD 8.082811
HNL 26.456145
HRK 7.461789
HTG 136.191512
HUF 412.656077
IDR 16890.51634
ILS 3.816574
IMP 0.823878
INR 88.526555
IQD 1364.405694
IRR 43782.54872
ISK 145.107732
JEP 0.823878
JMD 162.589008
JOD 0.737659
JPY 163.530588
KES 134.622118
KGS 90.504093
KHR 4176.999707
KMF 484.897784
KPW 936.246213
KRW 1511.221987
KWD 0.320611
KYD 0.867947
KZT 543.333931
LAK 22790.297087
LBP 93264.16857
LKR 308.396311
LRD 189.555004
LSL 19.1939
LTL 3.071659
LVL 0.629252
LYD 5.114568
MAD 10.479005
MDL 19.17354
MGA 4910.170813
MKD 61.498942
MMK 3378.770076
MNT 3534.851652
MOP 8.334912
MRU 41.473967
MUR 48.736726
MVR 16.021999
MWK 1806.037537
MXN 21.00156
MYR 4.671866
MZN 66.477402
NAD 19.1939
NGN 1611.395012
NIO 38.326709
NOK 11.821411
NPR 141.920851
NZD 1.842971
OMR 0.400511
PAB 1.041476
PEN 3.884948
PGK 4.225252
PHP 60.918978
PKR 290.199386
PLN 4.266137
PYG 8131.030881
QAR 3.797082
RON 4.975736
RSD 116.998606
RUB 105.300239
RWF 1442.444148
SAR 3.907617
SBD 8.721196
SCR 14.50713
SDG 625.721598
SEK 11.494354
SGD 1.412021
SHP 0.823878
SLE 23.72519
SLL 21814.033329
SOS 595.275062
SRD 36.537536
STD 21531.575972
SVC 9.113485
SYP 2613.72043
SZL 19.188392
THB 35.694956
TJS 11.378124
TMT 3.651362
TND 3.317108
TOP 2.436424
TRY 36.681843
TTD 7.074468
TWD 33.999074
TZS 2504.46173
UAH 43.776352
UGX 3827.62666
USD 1.040274
UYU 46.598949
UZS 13437.753668
VES 53.649239
VND 26474.978804
VUV 123.503438
WST 2.874057
XAF 656.900551
XAG 0.035013
XAU 0.000398
XCD 2.811393
XDR 0.798474
XOF 656.922685
XPF 119.331742
YER 260.458683
ZAR 19.29381
ZMK 9363.723842
ZMW 28.822846
ZWL 334.967873
  • NGG

    0.5200

    59.02

    +0.88%

  • BCC

    -0.5100

    122.24

    -0.42%

  • GSK

    0.4600

    34.06

    +1.35%

  • RIO

    0.5900

    59.23

    +1%

  • BP

    0.1500

    28.75

    +0.52%

  • SCS

    -0.0900

    11.65

    -0.77%

  • JRI

    0.0400

    12.1

    +0.33%

  • BCE

    -0.3200

    22.84

    -1.4%

  • BTI

    -0.0200

    36.22

    -0.06%

  • CMSC

    0.0420

    23.902

    +0.18%

  • RYCEF

    -0.0200

    7.25

    -0.28%

  • RELX

    0.1200

    45.59

    +0.26%

  • RBGPF

    0.0000

    60.5

    0%

  • VOD

    -0.0200

    8.37

    -0.24%

  • CMSD

    -0.0100

    23.55

    -0.04%

  • AZN

    1.2800

    66.63

    +1.92%

'Severe' pain: a New Yorker's experience of monkeypox
'Severe' pain: a New Yorker's experience of monkeypox / Photo: Yuki IWAMURA - AFP

'Severe' pain: a New Yorker's experience of monkeypox

"It was the worst pain that I have experienced in my life," says 26-year-old New Yorker Kyle Planck, recalling his recent monkeypox infection.

Text size:

Although anyone can catch monkeypox, Planck first took note of the virus in spring when authorities said many of the first cases in Europe and America were in men who have sex with men.

"I was a little bit worried that it would eventually affect us here in the United States, especially being a member of the LGBTQ+ community," he remembers.

At the end of June, the PhD candidate in pharmacology says he started to feel very sick.

A fever, swollen lymph nodes and a negative Covid-19 test made him think it could be monkeypox.

A doctor told him to wait and see how his symptoms evolved, but after four days of being feverish he developed spots that left him in no doubt.

"They had started on my arms and my hands and over the course of a day they spread all over my body.

"I had about 30 lesions develop at that point," he says at his apartment in the borough of Queens.

Planck was able to get tested on July 5 and the following day started treatment with TPOXX, or Tecovirimat, an antiviral drug originally used against human smallpox but authorized in a trial against monkeypox.

Planck concedes that his proximity to the medical community made it easier for him to enroll in a study.

"I know that is not the reality for most people in New York, which is really unfortunate," he says.

Monkeypox usually clears up on its own but can be extremely painful.

Planck was in intense pain for a week, especially from the lesions on his mucus membranes, before the drugs started to relieve his symptoms.

"The pain was so severe for me that I basically was taking warm baths six or seven times a day, just because that was the only thing that would make me feel better," he says.

Planck found the experience "exhausting" and adding to his stress was a fear of contaminating his roommate, even though transmission occurs by close contact.

He believes his case was "relatively mild" because he was able to receive treatment and that "so many people are going through worse."

Planck feels that US health authorities were too slow to react to the first outbreak of cases and says that preventative messaging has been too weak.

- Vaccine doses -

"I think the government was kind of like, 'let's wait and see what happens, let's wait and see if this becomes a problem,' and that really doesn't take into account how infectious diseases work," he says.

Planck has written multiple letters to elected officials asking them to increase access to the antiviral drug.

"We have millions of doses of the TPOXX treatment available. And months into this outbreak, we're still not really able to mobilize those resources," he says.

The United States initially had 100 million doses of the ACAM2000 vaccine. It is designed to treat human smallpox but can cause significant side effects and is not recommended for immunocompromised people.

Only a thousand doses of the newer and safer Jynneos vaccine were available as cases first started multiplying, largely because nearly 800,000 doses were blocked in Denmark pending approval by the Food and Drug Administration.

Availability is increasing, however.

New York City -- which has 711 confirmed cases, the highest concentrated number in the country -- has received 21,500 doses and is awaiting a supply of 25,000 more.

Appointments have gone in minutes and long queues have formed outside clinics in recent days.

"I don't want anyone to have to go through what I went through," concludes Planck.

D.Smith--NZN